186 related articles for article (PubMed ID: 3518399)
1. Immunohistochemical localization of CA 125 antigen in formalin-fixed paraffin sections of ovarian tumors with the use of Pronase.
Shishi J; Ghazizadeh M; Oguro T; Aihara K; Araki T
Am J Clin Pathol; 1986 May; 85(5):595-8. PubMed ID: 3518399
[TBL] [Abstract][Full Text] [Related]
2. Comparison between serum CA 125 and CA 19-9 assays and tissular OC 125 and 1116NS 19-9 reactivity in malignant and benign ovarian tumors.
Gadducci A; Ciancia EM; Malagnino G; De Luca F; Campani D; Ferdeghini M; Facchini V; Pingitore R; Fioretti P
Eur J Gynaecol Oncol; 1992; 13(4):346-54. PubMed ID: 1516586
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies.
Charpin C; Bhan AK; Zurawski VR; Scully RE
Int J Gynecol Pathol; 1982; 1(3):231-45. PubMed ID: 6193072
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors.
Tashiro Y; Yonezawa S; Kim YS; Sato E
Hum Pathol; 1994 Apr; 25(4):364-72. PubMed ID: 8163269
[TBL] [Abstract][Full Text] [Related]
5. A study of the Ca antigen in epithelial tumours of the ovary.
Ferguson AM; Fox H
J Clin Pathol; 1984 Jan; 37(1):6-9. PubMed ID: 6368598
[TBL] [Abstract][Full Text] [Related]
6. The value of tumour marker CA 125 in surgical pathology.
Koelma IA; Nap M; Rodenburg CJ; Fleuren GJ
Histopathology; 1987 Mar; 11(3):287-94. PubMed ID: 3480871
[TBL] [Abstract][Full Text] [Related]
7. Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA.
Neunteufel W; Breitenecker G
Gynecol Oncol; 1989 Mar; 32(3):297-302. PubMed ID: 2646183
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody, Mab 12C3, is a sensitive immunohistochemical marker of early malignant change in epithelial ovarian tumors.
Yamada K; Ohkawa K; Joh K
Am J Clin Pathol; 1995 Mar; 103(3):288-94. PubMed ID: 7872250
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody against human ovarian tumor-associated antigens.
Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
[TBL] [Abstract][Full Text] [Related]
10. Identification of a human cancer-associated antigen defined with monoclonal antibody.
Bhattacharya M; Chatterjee SK; Barlow JJ
Cancer Res; 1984 Oct; 44(10):4528-34. PubMed ID: 6380708
[TBL] [Abstract][Full Text] [Related]
11. Expression of Tn and sialyl-Tn antigens in tumor tissues of the ovary.
Inoue M; Ton SM; Ogawa H; Tanizawa O
Am J Clin Pathol; 1991 Dec; 96(6):711-6. PubMed ID: 1720922
[TBL] [Abstract][Full Text] [Related]
12. Six new monoclonal antibodies to serous, mucinous, and poorly differentiated ovarian adenocarcinomas.
Mettler L; Radzun HJ; Salmassi A; Köchling W; Parwaresch MR
Cancer; 1990 Apr; 65(7):1525-32. PubMed ID: 2178766
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical and ultrastructural localization of T antigen in ovarian tumors.
Ghazizadeh M; Oguro T; Sasaki Y; Aihara K; Araki T; Springer GF
Am J Clin Pathol; 1990 Mar; 93(3):315-21. PubMed ID: 1689937
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the specificity by immunohistology of a monoclonal antibody to a novel epithelial antigen of ovarian carcinomas.
Mariani-Costantini R; Agresti R; Colnaghi MI; Ménard S; Andreola S; Rilke F
Pathol Res Pract; 1985 Aug; 180(2):169-80. PubMed ID: 3903701
[TBL] [Abstract][Full Text] [Related]
15. [An immunohistochemical study of intestinal mucinous antigens and CEA in ovarian epithelial tumors].
Liu A; Wang M; Li H
Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):366-8. PubMed ID: 8732094
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
Friedman EL; Hayes DF; Kufe DW
Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay of the CA 12 5 antigen in ovarian carcinomas: advantages compared with CA 19-9 and CEA.
Ricolleau G; Chatal JF; Fumoleau P; Kremer M; Douillard JY; Curtet C
Tumour Biol; 1984; 5(3-4):151-9. PubMed ID: 6594738
[TBL] [Abstract][Full Text] [Related]
18. A tumor-associated antigen in carcinoma of the pancreas defined by monoclonal antibody B72.3.
Lyubsky S; Madariaga J; Lozowski M; Mishriki Y; Schuss A; Chao S; Lundy J
Am J Clin Pathol; 1988 Feb; 89(2):160-7. PubMed ID: 3277379
[TBL] [Abstract][Full Text] [Related]
19. Volume-corrected mitotic index and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors.
Miliaras D
Anal Quant Cytol Histol; 1999 Oct; 21(5):425-9. PubMed ID: 10560525
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Br J Cancer; 1986 Feb; 53(2):189-95. PubMed ID: 3513813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
